Intrahepatic cholestasis after liver transplantation

Hepatobiliary and Pancreatic Diseases International

Volumn 1, Issue 2, 2002, Pages 176-178

  Yang, Jia Mei ^a   Zhu, Bin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Intrahepatic cholestasis; Liver transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MACROLIDE; SULFAMETHOXAZOLE; SULFANILAMIDE; SULFONAMIDE; TACROLIMUS; URSODEOXYCHOLIC ACID;

ACUTE GRAFT REJECTION; ARTICLE; BILE DUCT OBSTRUCTION; CHOLANGITIS; CHRONIC GRAFT REJECTION; CYTOMEGALOVIRUS INFECTION; HEPATITIS B; HEPATITIS C; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LIVER TOXICITY; LIVER TRANSPLANTATION; PNEUMOCYSTIS PNEUMONIA; PRIMARY BILIARY CIRRHOSIS; RECIPIENT; TREATMENT OUTCOME;

BILE DUCT DISEASES; CHOLESTASIS, INTRAHEPATIC; GRAFT REJECTION; HEPATITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTION; LIVER TRANSPLANTATION; RECURRENCE; REOPERATION;

EID: 0038205785     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Singh N, Gayowski T. Cytomegalovirus and death in liver transplantation. Ann Intern Med 1997;127:412.
2. Green RM, Crawford JM. Hepatocellular cholestasis: pathobiology and histological outcome. Semin Liver Dis 1995;15:372-389.
3. Pasha TM, Lindor KD. Diagnosis and therapy of cholestatic liver disease. Med Clin North Am 1996; 80:995-1019.
4. van de Meeberg PC, van Erpecum KJ, van Berge-Henegouwen GP. Therapy with ursodeoxycholic acid in cholestatic liver disease. Scand J Gastroenterol (Suppl) 1993;200:15-20.
5. Donovan J. Nonsurgical management of biliary tract disease after liver transplantation. Gastroenterol Clin North Am 1993;22:317-336.